论文部分内容阅读
选择性肝动脉内药物灌注加栓塞治疗肝癌,已成为中晚期肝癌的主要治疗手段,其技术日臻成熟。在介入治疗过程中,栓塞剂的应用至关重要,但术中易发生较多并发症。对上述情况如何预防处理,对于患者的治疗及预后有着重要的实际意义。我院2000年3月—2008年4月,对肝癌栓塞治疗过程中
Selective hepatic artery drug infusion and embolization of liver cancer has become the main treatment for advanced liver cancer, the technology is maturing. In interventional therapy, the application of embolic agents is crucial, but intraoperative prone to more complications. How to prevent the above situation is of great practical significance for the treatment and prognosis of patients. Our hospital from March 2000 -2008 in April, the treatment of liver cancer embolization